On June 30, 2017, the board of directors of RespireRx Pharmaceuticals Inc. by unanimous written consent approved the amendment, effective July 1, 2017, of the employment agreement of Jeff Eliot Margolis, the company's Vice President, Secretary and Treasurer. Mr. Margolis is also a director of the company. The amendment includes the following terms: Mr. Margolis, who has been acting as interim chief financial officer, is now the chief financial officer of the company.

Mr. Margolis has been promoted from vice president to senior vice president.